155 related articles for article (PubMed ID: 34608415)
41. Development and validation of a prognostic nomogram for predicting overall survival in patients with primary bladder sarcoma: a SEER-based retrospective study.
Li S; Liu X; Chen X
BMC Urol; 2021 Nov; 21(1):162. PubMed ID: 34823525
[TBL] [Abstract][Full Text] [Related]
42. Development and Validation of the Nomograms for Predicting Overall Survival and Cancer-Specific Survival in Patients With Synovial Sarcoma.
Song Z; Cheng L; Lu L; Lu W; Zhou Y; Wang Z
Front Endocrinol (Lausanne); 2021; 12():764571. PubMed ID: 35308782
[TBL] [Abstract][Full Text] [Related]
43. Predictive Nomogram for Midterm to Long-Term Prognosis in Patients with Papillary Renal Cell Carcinoma Based on Data from the Surveillance, Epidemiology, and End Results (SEER) Program.
Wang H; Chen X; Zhao J; Kang M; Dong R; Wang K; Qu Y
Med Sci Monit; 2020 Jun; 26():e921859. PubMed ID: 32570266
[TBL] [Abstract][Full Text] [Related]
44. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study.
Yang Z; Bai Y; Liu M; Hu X; Han P
Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464
[TBL] [Abstract][Full Text] [Related]
45. Prognostic nomogram for predicting survival in patients with high grade endometrial stromal sarcoma: a Surveillance Epidemiology, and End Results database analysis.
Wu J; Zhang H; Li L; Hu M; Chen L; Wu S; Xu B; Song Q
Int J Gynecol Cancer; 2020 Oct; 30(10):1520-1527. PubMed ID: 32839227
[TBL] [Abstract][Full Text] [Related]
46. Specific survival nomograms based on SEER database for small intestine adenocarcinoma.
Wang D; Li C; Li Y; Liu W; Zhao L; Güngör C; Tan F; Zhou Y
Ann Palliat Med; 2021 Jul; 10(7):7440-7457. PubMed ID: 34263641
[TBL] [Abstract][Full Text] [Related]
47. Nomograms to Predict Overall and Cancer-Specific Survival in Gastric Signet-Ring Cell Carcinoma.
Chen CL; Xue DX; Chen HH; Liang MZ; Lin DZ; Yu M; Chen JX; Wu WL
J Surg Res; 2021 Oct; 266():13-26. PubMed ID: 33979736
[TBL] [Abstract][Full Text] [Related]
48. Development and Validation of a Nomogram-Based Prognostic Evaluation Model for Sarcomatoid Hepatocellular Carcinoma.
Ge D; Luo Z; Mao R; Zhao H; Lv X; Zhao J; Zhou J; Huang Z; Zhang Y; Li Z; Bi X; Cai J
Adv Ther; 2020 Jul; 37(7):3185-3205. PubMed ID: 32436026
[TBL] [Abstract][Full Text] [Related]
49. A Nomogram to Predict Individual Survival of Patients with Liver-Limited Metastases from Gastroenteropancreatic Neuroendocrine Neoplasms: A US Population-Based Cohort Analysis and Chinese Multicenter Cohort Validation Study.
Xu G; Xiao Y; Hu H; Jin B; Wu X; Wan X; Zheng Y; Xu H; Lu X; Sang X; Ge P; Mao Y; Cai J; Zhao H; Du S
Neuroendocrinology; 2022; 112(3):263-275. PubMed ID: 33902058
[TBL] [Abstract][Full Text] [Related]
50. Survival nomogram for patients with bone metastatic renal cell carcinoma: A population-based study.
Wang K; Wu Z; Wang G; Shi H; Xie J; Yin L; Xu T; Mao W; Peng B
Int Braz J Urol; 2021; 47(2):333-349. PubMed ID: 33284535
[TBL] [Abstract][Full Text] [Related]
51. The role of surgery for atypical bronchopulmonary carcinoid tumor: Development and validation of a model based on Surveillance, Epidemiology, and End Results (SEER) database.
Chen X; Pang Z; Wang Y; Bie F; Zeng Y; Wang G; Du J
Lung Cancer; 2020 Jan; 139():94-102. PubMed ID: 31759223
[TBL] [Abstract][Full Text] [Related]
52. A clinical model to predict distant metastasis in patients with superficial gastric cancer with negative lymph node metastasis and a survival analysis for patients with metastasis.
Chen J; Wu L; Zhang Z; Zheng S; Lin Y; Ding N; Sun J; Shi L; Xue M
Cancer Med; 2021 Feb; 10(3):944-955. PubMed ID: 33350173
[TBL] [Abstract][Full Text] [Related]
53. Prediction of Minor Salivary Gland Carcinoma: A Novel Nomogram and Risk Classification System for Overall Survival and Cancer-Specific Survival.
Lan LF; Gao CK; Ma CW
Otolaryngol Head Neck Surg; 2021 Feb; 164(2):359-368. PubMed ID: 32692284
[TBL] [Abstract][Full Text] [Related]
54. Development and validation of a nomogram to predict survival outcome among epithelial ovarian cancer patients with site-distant metastases: a population-based study.
Wang B; Wang S; Ren W
BMC Cancer; 2021 May; 21(1):609. PubMed ID: 34034697
[TBL] [Abstract][Full Text] [Related]
55. A Nomogram and a Risk Classification System Predicting the Cancer-Specific Survival of Patients With Initially-Diagnosed Osseous Spinal and Pelvic Tumors.
Zhou Q; Li AB; Lin ZQ; Zhang HZ
Spine (Phila Pa 1976); 2020 Jun; 45(12):E713-E720. PubMed ID: 32039945
[TBL] [Abstract][Full Text] [Related]
56. Nomograms for predicting survival in early-onset esophageal cancer.
Shi M; Tang JW; Cao ZR
Expert Rev Gastroenterol Hepatol; 2021 Apr; 15(4):437-446. PubMed ID: 33121317
[No Abstract] [Full Text] [Related]
57. Construction and validation of a nomogram to predict overall survival in patients with inflammatory breast cancer.
Diao JD; Ma LX; Sun MY; Wu CJ; Wang LJ; Liu YL; Yang YJ
Cancer Med; 2019 Sep; 8(12):5600-5608. PubMed ID: 31407527
[TBL] [Abstract][Full Text] [Related]
58. Development and validation of prognostic nomogram for germ cell testicular cancer patients.
Mao W; Wu J; Kong Q; Li J; Xu B; Chen M
Aging (Albany NY); 2020 Nov; 12(21):22095-22111. PubMed ID: 33136554
[TBL] [Abstract][Full Text] [Related]
59. Development and External Validation of a Clinical Nomogram for Individually Predicting Survival of Metaplastic Breast Cancer.
Wang J; Li Q; Luo Y; Han Y; Ma F; Cai R; Li Q; Fan Y; Wang J; Zhang P; Xu B
Clin Breast Cancer; 2022 Oct; 22(7):e798-e806. PubMed ID: 35961861
[TBL] [Abstract][Full Text] [Related]
60. Nomogram-Predicted Survival of Breast Cancer Brain Metastasis: a SEER-Based Population Study.
Xiong Y; Cao H; Zhang Y; Pan Z; Dong S; Wang G; Wang F; Li X
World Neurosurg; 2019 Aug; 128():e823-e834. PubMed ID: 31096027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
